FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

David Inwards

Research Profile

Concepts & Ideas

Procedures

Disorders

Phenomena

Recurrence

Chemicals & Drugs

Living Beings

Young Adult

Co-author Network

Publications

TOP 3
Luis F Porrata; Kay M Ristow; C A Thompson; T E Witzig; S M Ansell; Joseph P Colgan; T M Habermann; David J Inwards; Patrick B Johnston; William R Macon; Ivana N M Micallef; Grzegorz S Nowakowski; Svetomir N Markovic
Peripheral blood absolute lymphocyte/monocyte ratio recovery during ABVD treatment cycles predicts clinical outcomes in classical Hodgkin lymphoma.
Eoin P Flanagan; David J Inwards; Sean J Pittock; Paola Sandroni; Lyell K Jones
Paraneoplastic lower motor neuronopathy associated with Hodgkin lymphoma.
Luis F Porrata; Kay M Ristow; Carrie Thompson; Thomas E Witzig; Ivana N M Micallef; Grzegorz S Nowakowski; Nazan Ozsan; Stephen M Ansell; Joseph P Colgan; Ahmet Dogan; Thomas M Habermann; David J Inwards; Patrick B Johnston; William R Macon; Svetomir N Markovic
Absolute monocyte/lymphocyte count prognostic score is independent of immunohistochemically determined cell of origin in predicting survival in diffuse large B-cell lymphoma.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of David Inwards (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Luis F Porrata; Kay M Ristow; C A Thompson; T E Witzig; S M Ansell; Joseph P Colgan; T M Habermann; David J Inwards; Patrick B Johnston; William R Macon; Ivana N M Micallef; Grzegorz S Nowakowski; Svetomir N Markovic
Peripheral blood absolute lymphocyte/monocyte ratio recovery during ABVD treatment cycles predicts clinical outcomes in classical Hodgkin lymphoma.
Blood cancer journal 2013;3():e110.
2012: Eoin P Flanagan; David J Inwards; Sean J Pittock; Paola Sandroni; Lyell K Jones
Paraneoplastic lower motor neuronopathy associated with Hodgkin lymphoma.
Muscle & nerve 2012;46(5):823-7.
2012: Luis F Porrata; Kay M Ristow; Carrie Thompson; Thomas E Witzig; Ivana N M Micallef; Grzegorz S Nowakowski; Nazan Ozsan; Stephen M Ansell; Joseph P Colgan; Ahmet Dogan; Thomas M Habermann; David J Inwards; Patrick B Johnston; William R Macon; Svetomir N Markovic
Absolute monocyte/lymphocyte count prognostic score is independent of immunohistochemically determined cell of origin in predicting survival in diffuse large B-cell lymphoma.
Leukemia & lymphoma 2012;53(11):2159-65.
2012: Anita D'Souza; Dennis A Gastineau; Morie Gertz; Suzanne R Hayman; William Hogan; David J Inwards; Patrick Johnston; Shaji Kumar; Robert Kyle; Martha Lacy; Mark R Litzow; Ivana N M Micallef; Luis F Porrata; Steven R Zeldenrust; Stephen M Ansell; Francis Buadi; David Dingli; Angela Dispenzieri
Long-term outcomes after autologous stem cell transplantation for patients with POEMS syndrome (osteosclerotic myeloma): a single-center experience.
Blood 2012;120(1):56-62.
2012: Andrew P Sciallis; Ahmet Dogan; David J Inwards; Paul J Kurtin; Mark E Law; William R Macon; Rebecca F McClure; Andrew L Feldman
Mucosal CD30-positive T-cell lymphoproliferations of the head and neck show a clinicopathologic spectrum similar to cutaneous CD30-positive T-cell lymphoproliferative disorders.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2012;25(7):983-92.
2012: Luis F Porrata; Kay M Ristow; Carrie Thompson; Thomas E Witzig; Stephen M Ansell; Joseph P Colgan; Thomas M Habermann; David J Inwards; Patrick B Johnston; Ivana N M Micallef; Grzegorz S Nowakowski; Svetomir N Markovic
Peripheral blood lymphocyte/monocyte ratio at diagnosis and survival in nodular lymphocyte-predominant Hodgkin lymphoma.
British journal of haematology 2012;157(3):321-30.
2012: Ryan A Wilcox; Thomas E Witzig; Kay M Ristow; Stephen M Ansell; Joseph P Colgan; Thomas M Habermann; David J Inwards; Patrick B Johnston; Svetomir N Markovic; Ivana N M Micallef; Grzegorz S Nowakowski; Luis F Porrata
The absolute monocyte count is associated with overall survival in patients newly diagnosed with follicular lymphoma.
Leukemia & lymphoma 2012;53(4):575-80.
2012: Tait D Shanafelt; Susan L Slager; Carrie A Thompson; Thomas E Witzig; Clive S Zent; David J Inwards; Neil E Kay; Jose F Leis; Kari G Rabe; Susan M Schwager; Deborah A Bowen; Timothy G Call
Hematologist/oncologist disease-specific expertise and survival: lessons from chronic lymphocytic leukemia (CLL)/small lymphocytic lymphoma (SLL).
Cancer 2012;118(7):1827-37.
2011: Thomas E Witzig; Cristine Allmer; Stephen M Ansell; Joseph P Colgan; Husheng Ding; Mamta Gupta; Thomas M Habermann; Ray Hohl; David J Inwards; Patrick B Johnston; Paul J Kurtin; Brian K Link; David Loegering; Svetomir N Markovic; Matthew J Maurer; Ivana N M Micallef; Grzegorz S Nowakowski; Kevin Peterson; Luis F Porrata; Paula Schneider; Hui Tang; Carrie A Thompson; George Weiner; Scott H Kaufmann
Multi-institutional phase 2 study of the farnesyltransferase inhibitor tipifarnib (R115777) in patients with relapsed and refractory lymphomas.
Blood 2011;118(18):4882-9.
2011: Ryan A Wilcox; Thomas E Witzig; Kay M Ristow; Stephen M Ansell; Joseph P Colgan; Thomas M Habermann; David J Inwards; Patrick B Johnston; Svetomir N Markovic; Ivana N M Micallef; Grzegorz S Nowakowski; Luis F Porrata
The absolute monocyte and lymphocyte prognostic score predicts survival and identifies high-risk patients in diffuse large-B-cell lymphoma.
Leukemia 2011;25(9):1502-9.
2011: S Sinha; Jeffrey L Winters; Martha Lacy; Mark R Litzow; Ivana N M Micallef; Luis F Porrata; Stephen M Ansell; Francis Buadi; David Dingli; Angela Dispenzieri; Dennis A Gastineau; Morie A Gertz; C Greiner; Suzanne R Hayman; W Hogan; David J Inwards; P Johnston; Shaji Kumar
Predicting PBSC harvest failure using circulating CD34 levels: developing target-based cutoff points for early intervention.
Bone marrow transplantation 2011;46(7):943-9.
2011: Stephen M Ansell; Hui Tang; Paul J Kurtin; Patricia A Koenig; David J Inwards; Keith Shah; Steven C Ziesmer; Andrew L Feldman; Radha Rao; Mamta Gupta; Charles Erlichman; Thomas E Witzig
Temsirolimus and rituximab in patients with relapsed or refractory mantle cell lymphoma: a phase 2 study.
The lancet oncology 2011;12(4):361-8.
2011: Harris V K Naina; R K Pruthi; David J Inwards; David Dingli; Mark R Litzow; Stephen M Ansell; H J William; Angela Dispenzieri; Francis Buadi; Michelle A Elliott; Dennis A Gastineau; Morie A Gertz; Suzanne R Hayman; Patrick B Johnston; Martha Q Lacy; Ivana N M Micallef; Luis F Porrata; Shaji Kumar
Low risk of symptomatic venous thromboembolic events during growth factor administration for PBSC mobilization.
Bone marrow transplantation 2011;46(2):291-3.
2010: Morie A Gertz; Martha Q Lacy; Angela Dispenzieri; Suzanne R Hayman; Shaji K Kumar; David Dingli; Stephen M Ansell; Dennis A Gastineau; David J Inwards; Patrick B Johnston; Mark R Litzow; Ivana N M Micallef; Luis F Porrata; Nelson Leung; William J Hogan; Francis K Buadi
Autologous stem cell transplant for immunoglobulin light chain amyloidosis: a status report.
Leukemia & lymphoma 2010;51(12):2181-7.
2010: Thorvardur R Halfdanarson; Alberto Rubio-Tapia; Kay M Ristow; Thomas M Habermann; Joseph A Murray; David J Inwards
Patients with celiac disease and B-cell lymphoma have a better prognosis than those with T-cell lymphoma.
Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 2010;8(12):1042-7.
2010: Shernan G Holtan; William J Hogan; Michelle A Elliott; Stephen M Ansell; David J Inwards; Luis F Porrata; Patrick B Johnston; Ivana N M Micallef; Martha Q Lacy; Dennis A Gastineau; Mark R Litzow
CD34+ cell dose and establishment of full donor chimerism at day +100 are important factors for survival with reduced-intensity conditioning with fludarabine and melphalan before allogeneic hematopoietic SCT for hematologic malignancies.
Bone marrow transplantation 2010;45(12):1699-703.
2010: Luis F Porrata; Kay M Ristow; Thomas M Habermann; David J Inwards; Ivana N M Micallef; Svetomir N Markovic
Predicting survival for diffuse large B-cell lymphoma patients using baseline neutrophil/lymphocyte ratio.
American journal of hematology 2010;85(11):896-9.
2010: Amber D Khanna; Harold M Burkhart; Marosh Manduch; Andrew L Feldman; David J Inwards; Heidi M Connolly
Composite hodgkin and non-hodgkin lymphoma of the mitral and aortic valves.
Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography 2010;23(10):1113.e5-7.
2010: Matthew T Drake; Matthew J Maurer; Brian K Link; Thomas M Habermann; Stephen M Ansell; Ivana N Micallef; Jennifer L Kelly; William R Macon; Grzegorz S Nowakowski; David J Inwards; Patrick B Johnston; Ravinder J Singh; Cristine Allmer; Susan L Slager; George J Weiner; Thomas E Witzig; James R Cerhan
Vitamin D insufficiency and prognosis in non-Hodgkin's lymphoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2010;28(27):4191-8.
2010: Luis F Porrata; K Rsitow; David J Inwards; Stephen M Ansell; Ivana N M Micallef; Patrick B Johnston; Thomas M Habermann; Thomas E Witzig; J P Colgan; Grzegorz S Nowakowski; C A Thompson; Svetomir N Markovic
Lymphopenia assessed during routine follow-up after immunochemotherapy (R-CHOP) is a risk factor for predicting relapse in patients with diffuse large B-cell lymphoma.
Leukemia 2010;24(7):1343-9.
2010: Angela Dispenzieri; Gregory A Wiseman; Martha Q Lacy; Suzanne R Hayman; Shaji K Kumar; Francis Buadi; David Dingli; Krista M Laumann; Jake Allred; Susan M Geyer; Mark R Litzow; Dennis A Gastineau; David J Inwards; Ivana N M Micallef; Stephen M Ansell; Luis F Porrata; Michelle A Elliott; Patrick B Johnston; William J Hogan; Morie A Gertz
A Phase II study of (153)Sm-EDTMP and high-dose melphalan as a peripheral blood stem cell conditioning regimen in patients with multiple myeloma.
American journal of hematology 2010;85(6):409-13.
2010: Patrick B Johnston; David J Inwards; Joseph P Colgan; Betsy R Laplant; Brian F Kabat; Thomas M Habermann; Ivana N M Micallef; Luis F Porrata; Stephen M Ansell; Craig B Reeder; Vivek Roy; Thomas E Witzig
A Phase II trial of the oral mTOR inhibitor everolimus in relapsed Hodgkin lymphoma.
American journal of hematology 2010;85(5):320-4.
2010: Andrew L Feldman; Mark E Law; David J Inwards; Ahmet Dogan; Rebecca F McClure; William R Macon
PAX5-positive T-cell anaplastic large cell lymphomas associated with extra copies of the PAX5 gene locus.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2010;23(4):593-602.
2010: Luis F Porrata; David J Inwards; Stephen M Ansell; Ivana N M Micallef; Patrick B Johnston; William J Hogan; Svetomir N Markovic
New-onset lymphopenia assessed during routine follow-up is a risk factor for relapse postautologous peripheral blood hematopoietic stem cell transplantation in patients with diffuse large B-cell lymphoma.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2010;16(3):376-83.
2010: Mark R Litzow; Prema P Peethambaram; Stephanie L Safgren; Gary L Keeney; Stephen M Ansell; Angela Dispenzieri; Michelle A Elliott; Dennis A Gastineau; Morie A Gertz; David J Inwards; Martha Q Lacy; Ivana N M Micallef; Luis F Porrata; W L Lingle; Lynn C Hartmann; M H Frost; B A Barrette; Harry J Long; Vera J Suman; Joel M Reid; Matthew M Ames; S H Kaufmann
Phase I trial of autologous hematopoietic SCT with escalating doses of topotecan combined with CY and carboplatin in patients with relapsed or persistent ovarian or primary peritoneal carcinoma.
Bone marrow transplantation 2010;45(3):490-7.
2009: Luis F Porrata; Kay M Ristow; Thomas M Habermann; Thomas E Witzig; David J Inwards; Svetomir N Markovic
Absolute lymphocyte count at the time of first relapse predicts survival in patients with diffuse large B-cell lymphoma.
American journal of hematology 2009;84(2):93-7.
2008: Morie A Gertz; Stephen M Ansell; David Dingli; Angela Dispenzieri; Francis K Buadi; Michelle A Elliott; Dennis A Gastineau; Suzanne R Hayman; William J Hogan; David J Inwards; Patrick B Johnston; Shaji Kumar; Martha Q Lacy; Nelson Leung; Ivana N M Micallef; Luis F Porrata; Barbara A Schafer; Robert C Wolf; Mark R Litzow
Autologous stem cell transplant in 716 patients with multiple myeloma: low treatment-related mortality, feasibility of outpatient transplant, and effect of a multidisciplinary quality initiative.
Mayo Clinic proceedings. Mayo Clinic 2008;83(10):1131-8.
2008: Luciano J Costa; Ivana N M Micallef; David J Inwards; Patrick B Johnston; Luis F Porrata; Mark R Litzow; Stephen M Ansell
Effect of the dose per body weight of conditioning chemotherapy on severity of mucositis and risk of relapse after autologous haematopoietic stem cell transplantation in relapsed diffuse large B cell lymphoma.
British journal of haematology 2008;143(2):268-73.
2008: Pankaj Malhotra; William J Hogan; Mark R Litzow; Michelle A Elliott; Dennis A Gastineau; Stephen M Ansell; Angela Dispenzieri; Morie A Gertz; Suzanne R Hayman; David J Inwards; Martha Q Lacy; Ivana N M Micallef; Luis F Porrata; Ayalew Tefferi
Long-term outcome of allogeneic stem cell transplantation in chronic lymphocytic leukemia: analysis after a minimum follow-up of 5 years.
Leukemia & lymphoma 2008;49(9):1724-30.
2008: Stephen M Ansell; David J Inwards; Kendrith M Rowland; Patrick J Flynn; Roscoe F Morton; Dennis F Moore; Scott H Kaufmann; Irene M Ghobrial; Paul J Kurtin; Matthew Maurer; Cristine Allmer; Thomas E Witzig
Low-dose, single-agent temsirolimus for relapsed mantle cell lymphoma: a phase 2 trial in the North Central Cancer Treatment Group.
Cancer 2008;113(3):508-14.
2008: Luis F Porrata; David J Inwards; Stephen M Ansell; Ivana N Micallef; Patrick B Johnston; Dennis A Gastineau; Mark R Litzow; Jeffrey L Winters; Svetomir N Markovic
Early lymphocyte recovery predicts superior survival after autologous stem cell transplantation in non-Hodgkin lymphoma: a prospective study.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2008;14(7):807-16.
2008: Luciano J Costa; Andrew L Feldman; Ivana N M Micallef; David J Inwards; Patrick B Johnston; Luis F Porrata; Stephen M Ansell
Germinal center B (GCB) and non-GCB cell-like diffuse large B cell lymphomas have similar outcomes following autologous haematopoietic stem cell transplantation.
British journal of haematology 2008;142(3):404-12.
2008: David J Inwards; Paul A. Fishkin; David W Hillman; David W Brown; Stephen M Ansell; Paul J Kurtin; Rafael Fonseca; Roscoe F Morton; Michael H Veeder; Thomas E Witzig
Long-term results of the treatment of patients with mantle cell lymphoma with cladribine (2-CDA) alone (95-80-53) or 2-CDA and rituximab (N0189) in the North Central Cancer Treatment Group.
Cancer 2008;113(1):108-16.
2008: Angela Dispenzieri; Martha Q Lacy; Suzanne R Hayman; Shaji K Kumar; Francis Buadi; David Dingli; Mark R Litzow; Dennis A Gastineau; David J Inwards; Michelle A Elliott; Ivana N M Micallef; Stephen M Ansell; William J Hogan; Luis F Porrata; Patrick A Johnston; Bekele Afessa; Alan Bryce; Robert A Kyle; Morie A Gertz
Peripheral blood stem cell transplant for POEMS syndrome is associated with high rates of engraftment syndrome.
European journal of haematology 2008;80(5):397-406.
2008: Luciano J Costa; Ivana N M Micallef; David J Inwards; Patrick B Johnston; Luis F Porrata; Stephen M Ansell
Time of relapse after initial therapy significantly adds to the prognostic value of the IPI-R in patients with relapsed DLBCL undergoing autologous stem cell transplantation.
Bone marrow transplantation 2008;41(8):715-20.
2008: Stephen M Ansell; Thomas E Witzig; David J Inwards; Luis F Porrata; Arnaud Ythier; Lee Ferrande; Ivan Nestorov; Todd Devries; Stacey R Dillon; Diana Hausman; Anne J Novak
Phase I clinical study of atacicept in patients with relapsed and refractory B-cell non-Hodgkin's lymphoma.
Clinical cancer research : an official journal of the American Association for Cancer Research 2008;14(4):1105-10.
2007: Luis F Porrata; Kay M Ristow; Thomas E Witzig; N Tuinistra; Thomas M Habermann; David J Inwards; Stephen M Ansell; Ivana N M Micallef; Patrick B Johnston; Svetomir N Markovic
Absolute lymphocyte count predicts therapeutic efficacy and survival at the time of radioimmunotherapy in patients with relapsed follicular lymphomas.
Leukemia 2007;21(12):2554-6.
2007: Lijo Simpson; Stephen M Ansell; Joseph P Colgan; Thomas M Habermann; David J Inwards; Kay M Ristow; Patrick B Johnston; Svetomir N Markovic; Ivana N M Micallef; Luis F Porrata; Thomas E Witzig
Effectiveness of second line salvage chemotherapy with ifosfamide, carboplatin, and etoposide in patients with relapsed diffuse large B-cell lymphoma not responding to cis-platinum, cytosine arabinoside, and dexamethasone.
Leukemia & lymphoma 2007;48(7):1332-7.
2007: Thomas E Witzig; David J Inwards; Thomas M Habermann; Ahmet Dogan; Paul J Kurtin; John B Gross; Anuradha Ananthamurthy; Kay M Ristow; James A Garity
Treatment of benign orbital pseudolymphomas with the monoclonal anti-CD20 antibody rituximab.
Mayo Clinic proceedings. Mayo Clinic 2007;82(6):692-9.
2007: Deepti Behl; Kay M Ristow; Svetomir N Markovic; Thomas E Witzig; Thomas M Habermann; Joseph P Colgan; David J Inwards; William L White; Stephen M Ansell; Ivana N M Micallef; Patrick B Johnston; Luis F Porrata
Absolute lymphocyte count predicts therapeutic efficacy of rituximab therapy in follicular lymphomas.
British journal of haematology 2007;137(5):409-15.
2007: Shernan G Holtan; Luis F Porrata; Ivana N M Micallef; Douglas J Padley; David J Inwards; Stephen A Ansell; Patrick B Johnston; Dennis A Gastineau; Svetomir N Markovic
AMD3100 affects autograft lymphocyte collection and progression-free survival after autologous stem cell transplantation in non-Hodgkin lymphoma.
Clinical lymphoma & myeloma 2007;7(4):315-8.
2006: Ivana N M Micallef; Brad S Kahl; Matthew J Maurer; Ahmet Dogan; Stephen M Ansell; Joseph P Colgan; Susan Geyer; David J Inwards; William L White; Thomas M Habermann
A pilot study of epratuzumab and rituximab in combination with cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy in patients with previously untreated, diffuse large B-cell lymphoma.
Cancer 2006;107(12):2826-32.
2006: Ivana N M Micallef; Ellen D Remstein; Stephen M Ansell; Joseph P Colgan; David J Inwards; Patrick B Johnston; Jason T Lewis; Svetomir N Markovic; Luis F Porrata; William L White; Thomas E Witzig; Kay M Ristow; Thomas M Habermann
The International Prognostic Index predicts outcome after histological transformation of low-grade non-Hodgkin lymphoma.
Leukemia & lymphoma 2006;47(9):1794-9.
2006: Alan H Bryce; Angela Dispenzieri; Robert A Kyle; Martha Q Lacy; S Vincent Rajkumar; David J Inwards; Christopher A Yasenchak; Shaji Kumar; Morie A Gertz
Response to rituximab in patients with type II cryoglobulinemia.
Clinical lymphoma & myeloma 2006;7(2):140-4.
2006: Mustaqeem Siddiqui; Kay M Ristow; Svetomir N Markovic; Thomas E Witzig; Thomas M Habermann; Joseph P Colgan; David J Inwards; William L White; Stephen M Ansell; Ivana N M Micallef; Patrick B Johnston; Timothy G Call; Luis F Porrata
Absolute lymphocyte count predicts overall survival in follicular lymphomas.
British journal of haematology 2006;134(6):596-601.
2006: Shernan G Holtan; Luis F Porrata; David J Inwards; Stephen M Ansell; Ivana N M Micallef; Patrick B Johnston; Mark R Litzow; Dennis A Gastineau; Svetomir N Markovic
Timing of autologous stem cell transplantation from last chemotherapy affects lymphocyte collection and survival in non-Hodgkin lymphoma.
British journal of haematology 2006;133(6):628-33.
2006: Francis Buadi; Ivana N M Micallef; Stephen M Ansell; Luis F Porrata; Angela Dispenzieri; MA Elliot; Dennis A Gastineau; Morie A Gertz; Martha Q Lacy; Mark R Litzow; Ayalew Tefferi; David J Inwards
Autologous hematopoietic stem cell transplantation for older patients with relapsed non-Hodgkin's lymphoma.
Bone marrow transplantation 2006;37(11):1017-22.
2006: Michelle A Elliott; Ayalew Tefferi; William J Hogan; Louis Letendre; Dennis A Gastineau; Stephen M Ansell; Angela Dispenzieri; Morie A Gertz; Suzanne R Hayman; David J Inwards; Martha Q Lacy; Ivana N M Micallef; Luis F Porrata; Mark R Litzow
Allogeneic stem cell transplantation and donor lymphocyte infusions for chronic myelomonocytic leukemia.
Bone marrow transplantation 2006;37(11):1003-8.
2006: C Joao; Luis F Porrata; David J Inwards; Stephen M Ansell; Ivana N M Micallef; Patrick B Johnston; Dennis A Gastineau; Svetomir N Markovic
Early lymphocyte recovery after autologous stem cell transplantation predicts superior survival in mantle-cell lymphoma.
Bone marrow transplantation 2006;37(9):865-71.
2006: Angela Dispenzieri; Martha Q Lacy; Jerry A Katzmann; S Vincent Rajkumar; Roshini S Abraham; Suzanne R Hayman; Shaji Kumar; Raynell Clark; Robert A Kyle; Mark R Litzow; David J Inwards; Stephen M Ansell; Ivana M Micallef; Luis F Porrata; Michelle A Elliott; Patrick B Johnston; Philip R Greipp; Thomas E Witzig; Steven R Zeldenrust; stephen russell; Dennis A Gastineau; Morie A Gertz
Absolute values of immunoglobulin free light chains are prognostic in patients with primary systemic amyloidosis undergoing peripheral blood stem cell transplantation.
Blood 2006;107(8):3378-83.
2005: Yinlee Yoong; Luis F Porrata; David J Inwards; Stephen M Ansell; Ivana N M Micallef; Mark R Litzow; Morie A Gertz; Martha Q Lacy; Angela Dispenzieri; Dennis A Gastineau; Ayalew Tefferi; Michelle Elliott; Denis S Snow; William J Hogan; Svetomir N Markovic
The effect of absolute lymphocyte count recovery kinetics on survival after autologous stem cell transplantation for non-Hodgkin's lymphoma.
Leukemia & lymphoma 2005;46(9):1287-94.
2005: Thomas E Witzig; Susan M Geyer; Irene M Ghobrial; David J Inwards; Rafael Fonseca; Paul J Kurtin; Stephen M Ansell; Ronnie F Luyun; Patrick J Flynn; Roscoe F Morton; Shaker R Dakhil; Howard Gross; Scott H Kaufmann
Phase II trial of single-agent temsirolimus (CCI-779) for relapsed mantle cell lymphoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(23):5347-56.
2005: Luis F Porrata; Morie A Gertz; Mark R Litzow; Martha Q Lacy; Angela Dispenzieri; David J Inwards; Stephen M Ansell; Ivana N M Micallef; Dennis A Gastineau; Michele Elliott; William J Hogan; Suzanne R Hayman; Ayalew Tefferi; Svetomir N Markovic
Early lymphocyte recovery predicts superior survival after autologous hematopoietic stem cell transplantation for patients with primary systemic amyloidosis.
Clinical cancer research : an official journal of the American Association for Cancer Research 2005;11(3):1210-8.
2005: Angela Dispenzieri; Gregory A Wiseman; Martha Q Lacy; Mark R Litzow; Peter M Anderson; Dennis A Gastineau; Ayalew Tefferi; David J Inwards; Ivana N M Micallef; S M Ansell; Luis F Porrata; Michelle A Elliott; John A Lust; Philip R Greipp; S Vincent Rajkumar; R Fonseca; Thomas E Witzig; C Erlichman; J A Sloan; Morie A Gertz
A phase I study of 153Sm-EDTMP with fixed high-dose melphalan as a peripheral blood stem cell conditioning regimen in patients with multiple myeloma.
Leukemia 2005;19(1):118-25.
2004: Morie A Gertz; Martha Q Lacy; Angela Dispenzieri; S M Ansell; Michelle A Elliott; Dennis A Gastineau; David J Inwards; Ivana N M Micallef; Luis F Porrata; Ayalew Tefferi; Mark R Litzow
Risk-adjusted manipulation of melphalan dose before stem cell transplantation in patients with amyloidosis is associated with a lower response rate.
Bone marrow transplantation 2004;34(12):1025-31.
2004: Angela Dispenzieri; Morie A Gertz; Robert A Kyle; Martha Q Lacy; Mary F Burritt; Terry M Therneau; Joseph P McConnell; Mark R Litzow; Dennis A Gastineau; Ayalew Tefferi; David J Inwards; Ivana N M Micallef; Stephen M Ansell; Luis F Porrata; Michelle A Elliott; William J Hogan; S Vincent Rajkumar; Rafael Fonseca; Philip R Greipp; Thomas E Witzig; John A Lust; Steven R Zeldenrust; Denise S Snow; Suzanne R Hayman; Christopher G A McGregor; Allan S Jaffe
Prognostication of survival using cardiac troponins and N-terminal pro-brain natriuretic peptide in patients with primary systemic amyloidosis undergoing peripheral blood stem cell transplantation.
Blood 2004;104(6):1881-7.
2004: Angela Dispenzieri; Robert A Kyle; Martha Q Lacy; Terry M Therneau; Dirk R Larson; Matthew F Plevak; S Vincent Rajkumar; Rafael Fonseca; Philip R Greipp; Thomas E Witzig; John A Lust; Steven R Zeldenrust; Denise S Snow; Suzanne R Hayman; Mark R Litzow; Dennis A Gastineau; Ayalew Tefferi; David J Inwards; Ivana N M Micallef; Stephen M Ansell; Luis F Porrata; Michelle A Elliott; Morie A Gertz
Superior survival in primary systemic amyloidosis patients undergoing peripheral blood stem cell transplantation: a case-control study.
Blood 2004;103(10):3960-3.
2004: Irene M Ghobrial; Robert C Wolf; Denise Pereira; Rafael Fonseca; William L White; Joseph P Colgan; Thomas M Habermann; David J Inwards; Svetomir N Markovic; Stephen M Ansell; Ivana N M Micallef; Luis F Porrata; Thomas E Witzig
Therapeutic options in patients with lymphoma and severe liver dysfunction.
Mayo Clinic proceedings. Mayo Clinic 2004;79(2):169-75.
2004: Luis F Porrata; Mark R Litzow; David J Inwards; Dennis A Gastineau; S Breanndan Moore; A A Pineda; Kevin Bundy; Douglas J Padley; D Persky; Stephen M Ansell; Ivana N M Micallef; Svetomir N Markovic
Infused peripheral blood autograft absolute lymphocyte count correlates with day 15 absolute lymphocyte count and clinical outcome after autologous peripheral hematopoietic stem cell transplantation in non-Hodgkin's lymphoma.
Bone marrow transplantation 2004;33(3):291-8.
2003: Alejandro A Rabinstein; Angela Dispenzieri; Ivana N M Micallef; David J Inwards; Mark R Litzow; Eelco F M Wijdicks
Acute neuropathies after peripheral blood stem cell and bone marrow transplantation.
Muscle & nerve 2003;28(6):733-6.
2003: Shaji Kumar; Michael G Chen; Dennis A Gastineau; Morie A Gertz; David J Inwards; Martha Q Lacy; Ayalew Tefferi; Mark R Litzow
Lymphocyte recovery after allogeneic bone marrow transplantation predicts risk of relapse in acute lymphoblastic leukemia.
Leukemia 2003;17(9):1865-70.
2003: R Howe; Ivana N M Micallef; David J Inwards; S M Ansell; G W Dewald; A Dispenzieri; Dennis A Gastineau; Morie A Gertz; Susan M Geyer; Curtis A Hanson; M Q Lacy; Ayalew Tefferi; M R Litzow
Secondary myelodysplastic syndrome and acute myelogenous leukemia are significant complications following autologous stem cell transplantation for lymphoma.
Bone marrow transplantation 2003;32(3):317-24.
2003: Michelle A Elliott; William L Nichols; Elizabeth A Plumhoff; Stephen M Ansell; Angela Dispenzieri; Dennis A Gastineau; Morie A Gertz; David J Inwards; Martha Q Lacy; Ivana N M Micallef; Ayalew Tefferi; Mark R Litzow
Posttransplantation thrombotic thrombocytopenic purpura: a single-center experience and a contemporary review.
Mayo Clinic proceedings. Mayo Clinic 2003;78(4):421-30.
2002: Mark R Litzow; Panagiotis D Repoussis; Georgene Schroeder; David Schembri-Wismayer; Kenneth P Batts; Peter M Anderson; Carola A S Arndt; Michael G Chen; Dennis A Gastineau; Morie A Gertz; David J Inwards; Martha Q Lacy; Ayalew Tefferi; Pierre Noël; Lawrence Solberg; Louis Letendre; H Clark Hoagland
Veno-occlusive disease of the liver after blood and marrow transplantation: analysis of pre- and post-transplant risk factors associated with severity and results of therapy with tissue plasminogen activator.
Leukemia & lymphoma 2002;43(11):2099-107.
2002: Morie A Gertz; Martha Q Lacy; Angela Dispenzieri; Dennis A Gastineau; Michael G Chen; Stephen M Ansell; David J Inwards; Ivana N M Micallef; Ayalew Tefferi; Mark R Litzow
Stem cell transplantation for the management of primary systemic amyloidosis.
The American journal of medicine 2002;113(7):549-55.
2002: Shaji Kumar; Robert C Wolf; Michael G Chen; Dennis A Gastineau; Morie A Gertz; David J Inwards; Martha Q Lacy; Ayalew Tefferi; Mark R Litzow
Omission of day +11 methotrexate after allogeneic bone marrow transplantation is associated with increased risk of severe acute graft-versus-host disease.
Bone marrow transplantation 2002;30(3):161-5.
2002: Luis F Porrata; David J Inwards; Ivana N M Micallef; Stephen M Ansell; Susan M Geyer; Svetomir N Markovic
Early lymphocyte recovery post-autologous haematopoietic stem cell transplantation is associated with better survival in Hodgkin's disease.
British journal of haematology 2002;117(3):629-33.
2001: Ayalew Tefferi; Shaji Kumar; Robert C Wolf; Martha Q Lacy; David J Inwards; J M Gloor; R C Albright; Patrick S Kamath; Mark R Litzow
Charcoal hemofiltration for hepatic veno-occlusive disease after hematopoietic stem cell transplantation.
Bone marrow transplantation 2001;28(10):997-9.
2001: Shaji Kumar; Michael G Chen; Dennis A Gastineau; Morie A Gertz; David J Inwards; Martha Q Lacy; Ayalew Tefferi; Mark R Litzow
Effect of slow lymphocyte recovery and type of graft-versus-host disease prophylaxis on relapse after allogeneic bone marrow transplantation for acute myelogenous leukemia.
Bone marrow transplantation 2001;28(10):951-6.
2001: Luis F Porrata; David J Inwards; Martha Q Lacy; Svetomir N Markovic
Immunomodulation of early engrafted natural killer cells with interleukin-2 and interferon-alpha in autologous stem cell transplantation.
Bone marrow transplantation 2001;28(7):673-80.
2001: Luis F Porrata; Morie A Gertz; David J Inwards; Mark R Litzow; Martha Q Lacy; Ayalew Tefferi; Dennis A Gastineau; Angela Dispenzieri; Stephen M Ansell; Ivana N M Micallef; Susan M Geyer; Svetomir N Markovic
Early lymphocyte recovery predicts superior survival after autologous hematopoietic stem cell transplantation in multiple myeloma or non-Hodgkin lymphoma.
Blood 2001;98(3):579-85.
2001: Shaji Kumar; Michael G Chen; Dennis A Gastineau; Morie A Gertz; David J Inwards; Martha Q Lacy; Ayalew Tefferi; W S Harmsen; Mark R Litzow
Prophylaxis of graft-versus-host disease with cyclosporine-prednisone is associated with increased risk of chronic graft-versus-host disease.
Bone marrow transplantation 2001;27(11):1133-40.
2000: Morie A Gertz; Martha Q Lacy; Dennis A Gastineau; David J Inwards; Michael G Chen; Ayalew Tefferi; Robert A Kyle; Mark R Litzow
Blood stem cell transplantation as therapy for primary systemic amyloidosis (AL).
Bone marrow transplantation 2000;26(9):963-9.
2000: Morie A Gertz; Martha Q Lacy; David J Inwards; Dennis A Gastineau; Ayalew Tefferi; Michael G Chen; Thomas E Witzig; Philip R Greipp; Mark R Litzow
Delayed stem cell transplantation for the management of relapsed or refractory multiple myeloma.
Bone marrow transplantation 2000;26(1):45-50.
2000: S N Markovic; David J Inwards; E A Frigas; R P Phyliky
Acquired C1 esterase inhibitor deficiency.
Annals of internal medicine 2000;132(2):144-50.
2000: Rafael Fonseca; Thomas M Habermann; Joseph P Colgan; Brian Patrick O'Neill; William L White; Thomas E Witzig; Kathleen S Egan; James A Martenson; Lawrence J Burgart; David J Inwards
Testicular lymphoma is associated with a high incidence of extranodal recurrence.
Cancer 2000;88(1):154-61.
1999: T M Habermann; J H Ryu; David J Inwards; P J Kurtin
Primary pulmonary lymphoma.
Seminars in oncology 1999;26(3):307-15.
1999: Morie A Gertz; Martha Q Lacy; David J Inwards; Michael G Chen; AA Pineda; Dennis A Gastineau; Philip R Greipp; John A Lust; Ayalew Tefferi; Thomas E Witzig; Robert A Kyle; Mark R Litzow
Early harvest and late transplantation as an effective therapeutic strategy in multiple myeloma.
Bone marrow transplantation 1999;23(3):221-6.
1998: A Tefferi; Brian Patrick O'Neill; David J Inwards
Late-onset cerebral toxoplasmosis after allogeneic bone marrow transplantation.
Bone marrow transplantation 1998;21(12):1285-6.
1998: A Palmas; Ayalew Tefferi; Jeffrey L Myers; J P Scott; S J Swensen; Michael G Chen; Dennis A Gastineau; Morie A Gertz; David J Inwards; Martha Q Lacy; Mark R Litzow
Late-onset noninfectious pulmonary complications after allogeneic bone marrow transplantation.
British journal of haematology 1998;100(4):680-7.
1997: Christine Luise Kempton; Paul J Kurtin; David J Inwards; P Wollan; D G Bostwick
Malignant lymphoma of the bladder: evidence from 36 cases that low-grade lymphoma of the MALT-type is the most common primary bladder lymphoma.
The American journal of surgical pathology 1997;21(11):1324-33.
1997: Morie A Gertz; Martha Q Lacy; David J Inwards; AA Pineda; Michael G Chen; Dennis A Gastineau; Ayalew Tefferi; Robert A Kyle; Mark R Litzow
Factors influencing platelet recovery after blood cell transplantation in multiple myeloma.
Bone marrow transplantation 1997;20(5):375-80.
1997: Stephen M Ansell; Thomas M Habermann; Paul J Kurtin; Thomas E Witzig; Michael G Chen; Chin-Yang Li; David J Inwards; Joseph P Colgan
Predictive capacity of the International Prognostic Factor Index in patients with peripheral T-cell lymphoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1997;15(6):2296-301.
1995: Morie A Gertz; Alvaro A Pineda; Michael G Chen; Louis Letendre; Philip R Greipp; Lawrence Solberg; Thomas E Witzig; J P Garton; David J Inwards; Mark R Litzow
Refractory and relapsing multiple myeloma treated by blood stem cell transplantation.
The American journal of the medical sciences 1995;309(3):152-61.
1991: David J Inwards; D G Piepgras; J T Lie; Brian Patrick O'Neill; B W Scheithauer; Thomas M Habermann
Granulomatous angiitis of the spinal cord associated with Hodgkin's disease.
Cancer 1991;68(6):1318-22.
1990: David J Inwards; Thomas M Habermann; P M Banks; Joseph P Colgan; Gordon W Dewald
Cytogenetic findings in 21 cases of peripheral T-cell lymphoma.
American journal of hematology 1990;35(2):88-95.